DURHAM, N.C.--(BUSINESS WIRE)--Bioventus, a global leader in orthobiologic solutions, today announced it has entered into an agreement with Seikagaku Corporation to continue distributing SUPARTZ FX™ in the US after the current distribution agreement expires in May 2017. Under terms of this extension, Bioventus will continue to distribute SUPARTZ FX in the US through May 2019.

“We are pleased that Bioventus will continue to provide physicians and patients with SUPARTZ FX beyond 2017,” said Tony Bihl, CEO of Bioventus. “HA products like SUPARTZ FX underscore our mission to help people resume and enjoy active lives.”

About Bioventus

Bioventus LLC is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus has two product portfolios for orthobiologics, Bioventus Active Healing Therapies and Bioventus Surgical that make it a global leader in active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.

For more information, visit www.BioventusGlobal.com and follow the company on Twitter @Bioventusglobal